Investing.com - Sesen Bio reported on Monday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Sesen Bio announced earnings per share of $0.100 on revenue of $40M. Analysts polled by Investing.com EPS of $-0.120 on revenue of $0.00.
Sesen Bio 's are down 32% and is trading at $0.548 , still down 59.10% from its 52 week high of $1.34 set on Monday, November 8, 2021.
Sesen Bio shares gained 1.20% to trade at $0.548 in intra-day trade the report.
Sesen Bio follows other major Healthcare sector earnings this month
Sesen Bio's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar